These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29774188)

  • 21. Gadofosveset: the first intravascular contrast agent EU-approved for use with magnetic resonance angiography.
    Goyen M
    Future Cardiol; 2007 Jan; 3(1):19-26. PubMed ID: 19804202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiological staging of colorectal liver metastases.
    Ong KO; Leen E
    Surg Oncol; 2007 Jul; 16(1):7-14. PubMed ID: 17499498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic ultrasound for the detection of hepatic metastases during laparoscopic colorectal cancer surgery.
    Hartley JE; Kumar H; Drew PJ; Heer K; Avery GR; Duthie GS; Monson JR
    Dis Colon Rectum; 2000 Mar; 43(3):320-4; discussion 324-5. PubMed ID: 10733112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resovist-enhanced MRI for preoperative assessment of colorectal hepatic metastases: a case of multiple bile duct hamartomas associated with colon cancer.
    Suzuki H; Tsurita G; Ishihara S; Akahane M; Kitayama J; Nagawa H
    Case Rep Gastroenterol; 2008 Sep; 2(3):509-16. PubMed ID: 21897808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology.
    Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM
    Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169
    [No Abstract]   [Full Text] [Related]  

  • 26. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas.
    Furuhata T; Okita K; Tsuruma T; Hata F; Kimura Y; Katsuramaki T; Mukaiya M; Hirokawa N; Ichimura T; Yama N; Koito K; Sasaki K; Hirata K
    Dig Surg; 2003; 20(4):321-5. PubMed ID: 12806198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thoracic magnetic resonance venography using Gadofosveset in patients with venous pathology-A comparative study of image quality and inter-rater variability.
    Åkesson M; Lehti L; Höglund P; Åkeson P; Wassélius J
    Phlebology; 2017 Aug; 32(7):453-458. PubMed ID: 27388453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
    Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
    Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
    Vilgrain V; Esvan M; Ronot M; Caumont-Prim A; Aubé C; Chatellier G
    Eur Radiol; 2016 Dec; 26(12):4595-4615. PubMed ID: 26883327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases.
    Cheung HMC; Karanicolas PJ; Coburn N; Seth V; Law C; Milot L
    Eur Radiol; 2019 Feb; 29(2):1032-1038. PubMed ID: 29992388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.
    Berger-Kulemann V; Schima W; Baroud S; Koelblinger C; Kaczirek K; Gruenberger T; Schindl M; Maresch J; Weber M; Ba-Ssalamah A
    Eur J Surg Oncol; 2012 Aug; 38(8):670-6. PubMed ID: 22652037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
    Mainenti PP; Mancini M; Mainolfi C; Camera L; Maurea S; Manchia A; Tanga M; Persico F; Addeo P; D'Antonio D; Speranza A; Bucci L; Persico G; Pace L; Salvatore M
    Abdom Imaging; 2010 Oct; 35(5):511-21. PubMed ID: 19562412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
    Kulemann V; Schima W; Tamandl D; Kaczirek K; Gruenberger T; Wrba F; Weber M; Ba-Ssalamah A
    Eur J Radiol; 2011 Aug; 79(2):e1-6. PubMed ID: 20392584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-resolved contrast-enhanced MRA (TWIST) with gadofosveset trisodium in the classification of soft-tissue vascular anomalies in the head and neck in children following updated 2014 ISSVA classification: first report on systematic evaluation of MRI and TWIST in a cohort of 47 children.
    Higgins LJ; Koshy J; Mitchell SE; Weiss CR; Carson KA; Huisman TA; Tekes A
    Clin Radiol; 2016 Jan; 71(1):32-9. PubMed ID: 26474946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver metastases of colorectal cancer: US, CT or MR?
    Schima W; Kulinna C; Langenberger H; Ba-Ssalamah A
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S149-56. PubMed ID: 16361131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
    Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
    Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform.
    Spanakis M; Marias K
    In Silico Pharmacol; 2014 Dec; 2(1):2. PubMed ID: 27502621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
    Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim MJ; Rinde H; Jonas E
    Eur Radiol; 2016 Nov; 26(11):4121-4130. PubMed ID: 26905871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.